The relationship between small intestinal bacterial overgrowth and constipation in children - a comprehensive review.


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2024
Historique:
received: 12 05 2024
accepted: 12 06 2024
medline: 12 7 2024
pubmed: 12 7 2024
entrez: 12 7 2024
Statut: epublish

Résumé

Small intestinal bacterial overgrowth (SIBO) is characterized by an increase in the bacterial population of the small intestine due to an imbalance between the amount of bacteria and the intestinal barrier. Pediatric SIBO presents with a wide spectrum of symptoms, ranging from mild gastrointestinal complaints to malabsorption or malnutrition. Breath tests are commonly used as noninvasive diagnostic tools for SIBO, but a standardized methodology is currently unavailable. Intestinal flora produces methane which slows intestinal transit and increases the contractile activity of small intestine. Emerging literature suggests a correlation between overgrowth of methanogenic bacteria in the intestines and constipation. Treatment of SIBO involves administration of antibacterial therapy in addition to management of underlying conditions and optimal dietary adjustments. However, research on antibiotic treatment for pediatric patients with constipation and SIBO is limited and has yielded conflicting results. In the current review, we summarize the state-of-the-art of the field and discuss previous treatment attempts and currently used regimens for SIBO patients with constipation, with a focus on pediatric populations.

Identifiants

pubmed: 38994003
doi: 10.3389/fcimb.2024.1431660
pmc: PMC11236546
doi:

Substances chimiques

Anti-Bacterial Agents 0
Methane OP0UW79H66

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1431660

Informations de copyright

Copyright © 2024 Mares, Săsăran and Mărginean.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Cristina Roxana Mares (CR)

Department of Pediatrics, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology of Târgu Mures, Târgu Mures, Romania.

Maria Oana Săsăran (MO)

Department of Pediatrics 3, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology of Târgu Mures, Târgu Mures, Romania.

Cristina Oana Mărginean (CO)

Department of Pediatrics 1, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology of Târgu Mures, Târgu Mures, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH